NISKAYUNA, N.Y.--(BUSINESS WIRE)--To accelerate and enhance the development of Metabolic Imaging and other innovative technology, GE has launched a new entity, Research Circle Technology Inc. (RCT). RCT’s vision is to create a strong- alliance between GE’s scientists and the world’s leading universities, providing easy access to GE’s organic technology and wide scope of Healthcare expertise in an open innovation structure.
“The launch of RCT is a significant step forward for GE Healthcare, reinventing our methods of engagement with both customers and industry thought leaders,” said Michael Harsh, Vice President and Chief Technology Officer for GE Healthcare. “Ultimately, RCT can help us execute our vision to develop and deliver groundbreaking new solutions in Healthcare technology.”
Already, global leaders of imaging technology and disease detection research have explored potential applications for metabolic imaging technology:
- University of California – San Francisco’s Surbeck Laboratory for Advanced Imaging has announced the groundbreaking results of a study utilizing GE’s 13C technology to study prostate cancer. “This is the first time researchers have used this technology to conduct real-time metabolic imaging in a human patient, and represents a revolutionary approach to assessing the precise outlines of a tumor, its response to treatment and how quickly it is growing, ”said Sarah J. Nelson, Ph.D., a professor of Radiology and Biomedical Imaging at UCSF. Dr. Nelson is presenting the team’s findings at the World Molecular Imaging Conference (WMIC) in San Diego this week.
- Scientists at Cancer Research UK’s Cambridge Research Institute have developed a technique to show the effectiveness of breast cancer treatment weeks earlier than current methods through metabolic imaging. According to Lead researcher Professor Kevin Brindle, “There has been a need to develop imaging methods that can help detect treatment response more accurately than traditional methods and before tumors change size. Our new imaging method not only shows early evidence that treatment is working but could also help predict the long term outcome. We expect that these techniques will have an impact for patients in the near future.”
Through RCT, GE looks to continue developing this innovative technology, providing the tools, services, and solutions so that leading researchers can focus on their investigations into the biochemistry of metabolism and speed the discovery of potentially lifesaving knowledge. RCT will sell SpinLab polarizers as well as provide the licensing framework for partners to continue to develop the Metabolic Imaging applications. RCT helps enable- GE to fully connect with the skills and knowledge of the research community, with the goal of transitioning technology from ‘bench to bedside’ more efficiently.
“The focused goal of RCT is open collaboration to bring Hyperpolarization technology to the worlds’ leading researchers and enable their studies to better understand the biochemistry of life,” said Jonathan A. Murray, Managing Director, Research Circle Technology. “The early results are very exciting and we are delighted to collaborate with this community to help bring this innovative technology to its full potential.”
About Research Circle Technology
Research Circle Technology Inc. (RCT), a new company under GE’s Technology Ventures (Licensing) business, was created to accelerate and enhance the development of new technology. This, wholly-owned entity combines GE Healthcare’s industry presence, GE Global Research’s world-class research and technology, and GE Technology Ventures’ expertise in intellectual property and licensing partnerships. With a focus on open innovation and collaborative partnerships with leading researchers, RCT redefines the way GE delivers solutions to the healthcare industry.
About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.
Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.
About GE Global Research
GE Global Research is the hub of technology development for all of GE's businesses. Our scientists and engineers redefine what’s possible, drive growth for our businesses and find answers to some of the world’s toughest problems.
We innovate 24 hours a day, with sites in Niskayuna, New York; Bangalore, India; Shanghai, China; Munich, Germany; and fifth global research facility to open in Rio de Janeiro, Brazil in 2012. Visit GE Global Research on the web at www.ge.com/research. Connect with our technologists at http://edisonsdesk.com and http://twitter.com/edisonsdesk.
GE (NYSE: GE) is an advanced technology, services and finance company taking on the world’s toughest challenges. Dedicated to innovation in energy, health, transportation and infrastructure, GE operates in more than 100 countries and employs about 300,000 people worldwide. For more information, visit the company’s Web site at www.ge.com.
GE’s Technology Ventures group, a component of Corporate Licensing, drives the technology commercialization and maximizes the business development opportunities of licensing portfolios for GE. With close ties to GE’s Global Research, Technology Ventures supports the protection, development and marketing of GE’s Intellectual Property on a global level, offering a dynamic combination of investing, licensing, industry and technical expertise.